We have discovered a library of ABC Pump Activators that are currently focused in the areas of immunosuppression (clinical program), metabolic disease (preclinical program), and CNS (preclinical program). Our platform of NCE Activators works by making existing/pipeline drugs safer or when used alone, can modify diseases such as hyperglycemia and hyperlipidemia.

We are actively seeking pharmaceutical and biotechnology partners on a worldwide basis to fully maximize the value of our platform. We welcome your inquires: limerick@limerickbio.com